We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Dr Raghuvanshi’s expertise lies in dosage form design and development, majorly in pharma innovation and has been involved in the development of different kind of products for global markets.
BR Sikri informed that in the 2nd IPCA meeting held at Mumbai with Dilip Shanghavi, most of the points were discussed with regards to arrangement and conduction of IPC